A randomised prospective trial comparing bioabsorbable versus titanium plates in the treatment of mandibular and zygomatic fractures

ISRCTN ISRCTN63274027
DOI https://doi.org/10.1186/ISRCTN63274027
Secondary identifying numbers N0265154611
Submission date
29/09/2006
Registration date
29/09/2006
Last edited
26/10/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Oral Health
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr K Webster
Scientific

Maxillofacial Surgery
Queen Elizabeth Hospital
Birmingham
B15 2TH
United Kingdom

Study information

Study designProspective single-blind randomised single-centre study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleA randomised prospective trial comparing bioabsorbable versus titanium plates in the treatment of mandibular and zygomatic fractures
Study objectivesMandibular and zygomatic fractures are conventually fixed by open reduction and internal fixation using titanium plates and screws. Between 18-35% of these plates are subsequently removed due to complications such as loosening.
Bioabsorbable plates are now available as an alternative to metal plates. The potential advantage of using resorbable plates is that the reoperation rate to remove titanium plates that develop complications would be greatly reduced.
The Inion(R) bioabsorbable material comprises the polymers L-polylactic acid, D/L-polylactic acid, trimethylene carbonate and polyglycolic acid. The material degrades by hydrolysis into carbon dioxide and water, in a similar fashion to "dissolving" sutures. The degradation profile provides initial stability to the facial bone and then progressive.
Although bioabsorbable plates have been used in facial fractures there is no prospective data to confirm that they are equivalent to titanium plates. A prospective comparison of the two systems would define whether bioabsorbable plates have a lower complication rate and whether a reduction in reoperation rate can be achieved.

The Null hypothesis to be answered is: there is no difference in the re-operation rate in mandibular and zygomatic fracture repair between titanium and Inion(R) bioabsorbable plates.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedOral Health
InterventionAll patients presenting to the maxillofacial trauma service at University Hospital Birmingham with mandibular and maxillary fractures will be randomised to two treatment arms:
1. Conventional treatment with ORIF using titanium miniplates
2. ORIF using bioabsorbable plates

Invasive procedures and investigations: no change in pre-operative workup will be required
Duration of study: outpatient review at 1 week, 6 weeks, six months and 12 months
End points/outcomes: a comparison of complication rates in each group.
Expected complications: infection, loosening of plates and screws, plate fracture, plate exposure (in mouth), malunion, non-union of fracture
Intervention typeProcedure/Surgery
Primary outcome measureThe rate of removal of resorbable vs non resorbable plates in facial fractures
Secondary outcome measuresNot provided at time of registration
Overall study start date01/03/2005
Completion date25/01/2008

Eligibility

Participant type(s)Patient
Age groupAdult
SexNot Specified
Target number of participantsNot provided at time of registration
Key inclusion criteria1. Healthy adult volunteers
2. Traumatic mandibular or zygomatic fractures
Key exclusion criteria1. Overt infection
2. Pregnancy
3. Under 16
4. Pathological fractures, prisoner, malignancy
Date of first enrolment01/03/2005
Date of final enrolment25/01/2008

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Queen Elizabeth Hospital
Birmingham
B15 2TH
United Kingdom

Sponsor information

Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Government

The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

University Hospital Birmingham NHS Trust (UK), NHS R&D Support Funding

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

26/10/2015: no publications found on PubMed.